The Aragonese Health Service adopts Legit.Health AI to strengthen dermatological diagnosis
- Primary care physicians and the dermatology departments in Aragón now have an AI-based second clinical opinion able to analyze images of skin lesions, offer differential diagnoses across more than 300 conditions and detect signs of severity or suspected malignancy.
- Embedded in the professional's workflow, the tool helps prioritize urgent referrals, such as possible skin cancer cases, and resolve mild cases in consultation, reducing waiting times for the patients who need it most.
Bilbao/Zaragoza, July 23, 2026. The artificial intelligence technology that the Government of Aragón has begun testing in its health service to improve the diagnosis of skin diseases is the one developed by Legit.Health. The company, specialized in artificial intelligence applied to dermatology, is responsible for the clinical decision support solution being piloted in four health centers and in the dermatology departments of two reference hospitals in Aragón, in a project driven by the Directorate-General for Digital Health and Infrastructure of the Department of Health and developed together with Telefónica Tech.
From a photograph of the lesion, the platform analyzes image quality, proposes differential diagnoses and estimates the severity of certain pathologies, offering professionals a second opinion that supports dermatological triage. Family doctors can thus prioritize urgent referrals, such as possible skin cancer cases, and resolve mild or moderate cases in consultation without referring them, which helps reduce waiting times for the patients who need it most. It is a technology certified as a medical device, with CE marking, where image capture can be done directly with a mobile phone or with the health centers' tablets.
"The Government of Aragón continues to drive the digital transformation strategy of Aragón's healthcare system, promoting the incorporation of advanced technologies that will contribute to improving care processes," says Joaquín Velilla, director-general of Digital Health and Infrastructure at the Department of Health of the Government of Aragón.
"That a public health system like Aragón's trusts our technology shows that dermatological artificial intelligence is now ready to add value right where the first clinical decision is made. It is not about replacing the professional's judgment, but about giving them tools to act with more information, prioritize at-risk cases, and offer more agile care to the patient," says Andy Aguilar, CEO and co-founder of Legit.Health.
The pilot, planned to run approximately until December 2026, takes place in the health centers of La Almozara, San José Centro, Miralbueno and Tauste, and in the dermatology departments of Hospital Universitario Miguel Servet and Hospital Clínico Universitario Lozano Blesa. The solution is embedded in the Aragonese Health Service's HCE Móvil application, which lets professionals use it within their usual workflow, including outside the conventional consultation.
About Legit.Health
Legit.Health is a medical technology company specialized in AI-based clinical decision support tools for dermatology. Its CE-marked software helps healthcare professionals improve diagnostic accuracy, standardize severity assessment and promote better clinical outcomes. With a focus on scientific validation and regulatory compliance, it serves hospitals, clinics and health systems throughout Europe. More information: https://legit.health/
About the Aragonese Health Service (SALUD)
The Aragonese Health Service (SALUD) is the public healthcare organization responsible for care to the population of Aragón. It manages a comprehensive network of hospitals, primary care centers and specialized facilities throughout the autonomous community, and reports to the Department of Health of the Government of Aragón. More information: www.saludinforma.es
Media Contact
Legit.Health Press Relations press@legit.health